Related Experiment Video
Updated: May 6, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Patterns of cardiac dysfunction coinciding with exertional breathlessness in hypertrophic cardiomyopathy
Dejan Maras1, Robin Chung, Alison Duncan
1Canterbury Christ Church University, Canterbury, UK.
Insights
Breathlessness in hypertrophic cardiomyopathy (HCM) is often due to left ventricular outflow tract (LVOT) obstruction or other cardiac dysfunctions. Identifying these specific causes is crucial for tailored patient management.
Area of Science:
- Cardiology
- Cardiovascular Physiology
Background:
- Breathlessness is a common symptom in hypertrophic cardiomyopathy (HCM).
- Left ventricular outflow tract (LVOT) obstruction is a frequent cause, but other mechanisms may contribute, similar to dilated cardiomyopathy.
Purpose of the Study:
- To assess cardiac function during symptomatic periods in unselected HCM patients.
- To identify patterns of cardiac dysfunction associated with breathlessness in HCM.
Main Methods:
- Doppler echocardiography was used in 37 HCM patients and 17 controls.
- Studies were conducted at rest and during dobutamine stress testing.
- Stress endpoints included symptoms, blood pressure drop, arrhythmia, or maximum dobutamine dose.
Main Results:
- HCM patients showed preserved ejection fraction but increased LVOT velocity and reduced long axis amplitude at rest.
- At peak stress, LVOT obstruction and mitral regurgitation developed in many patients.
- A subgroup without LVOT obstruction exhibited prolonged ejection time, impaired systolic amplitude, and altered filling dynamics.
Conclusions:
- Exertional breathlessness in HCM is linked to LVOT obstruction/mitral regurgitation in most patients.
- A significant minority experience breathlessness due to restrictive physiology or dyssynchrony at high heart rates.
- Distinct management strategies are needed based on the underlying mechanism of breathlessness.
Objective:
The commonest cause of breathlessness in hypertrophic cardiomyopathy (HCM) is left ventricular outflow tract (LVOT) obstruction which improves with its removal. However, in the absence of outflow tract obstruction, as in dilated cardiomyopathy, patients may be limited by similar symptoms, thus suggesting a potential common mechanism for the two conditions. We aimed to assess cardiac function at the time of symptoms in a group of unselected patients with HCM to identify other patterns of cardiac dysfunction which coincide with their breathlessness.
Methods:
We studied 37 HCM patients (aged 55 ± 15 years, 13 female) with septal thickness >15 mm and 17 controls (aged 58 ± 12 years, 12 female) using Doppler echocardiography, at rest and at peak dobutamine stress. Stress end points were symptoms, >20 mmHg drop in systolic blood pressure, arrhythmia, or maximum dobutamine dosage of 40 μg/kg/min.
Results:
At rest: LV systolic function was maintained (EF 68 ± 7 v 76 ± 12%, respectively), LVOT velocity raised (p<0.005), lateral and septal long axis amplitude reduced (p<0.05 and p<0.005, respectively) and dyssynchronous and QRS duration was also broader (p<0.005) in patients compared to controls. At peak stress: Overall LVOT velocities were higher in patients than controls (4.3 ± 1.7 v 1.7 ± 1.0m/s, p<0.005, respectively) due to systolic anterior movement of the mitral valve and mitral regurgitation developing. In the 15 patients who did not develop significant LVOT obstruction (velocity <4m/s), LV ejection time increased and peak systolic amplitude did not increase. In the 10 patients with neither LVOT obstruction nor restrictive filling, QRS duration prolonged by 12 ms (p <0.05), post-ejection shortening worsened and peak systolic amplitude fell (p<0.005). Also, LV ejection time prolonged by 5s/min (p<0.05), filling time failed to increase as it did in controls (p<0.005) and Tei index was higher than controls (p<0.01).
Conclusion:
Exertional breathlessness in HCM is associated with LV outflow tract obstruction and functional mitral regurgitation in almost two thirds of patients. The remaining one third have either resistant restrictive physiology or dyssynchronous cavity at fast heart rate. Despite similar exercise limiting breathlessness in the three groups, means of management should be quite different.
More Related Videos
08:35Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
08:45Echocardiographic Assessment Using Subxiphoid-Only Examination for Hypotensive Patients
Published on: April 18, 2025
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Heart Failure II: Pathophysiology
Mitral Stenosis II: Clinical features and Diagnostic Tests